...
机译:转移性胰腺导管腺癌:对未来的诊断和治疗
Department of Medical OncologyThe Kinghorn Cancer CentreDarlinghurst New South Wales Australia;
Department of Medical OncologyThe Kinghorn Cancer CentreDarlinghurst New South Wales Australia;
Department of Medical OncologyCrown Princess Mary Cancer CentreSydney New South Wales Australia;
Department of Medical OncologyThe Canberra HospitalCanberra Australian Capital Territory Australia;
Department of Medical OncologyThe Kinghorn Cancer CentreDarlinghurst New South Wales Australia;
pancreatic cancer; adenocarcinoma; metastatic; cytotoxic chemotherapy; clinical trials; cancer genomics;
机译:转移性胰腺导管腺癌:对未来的诊断和治疗
机译:转移性胰腺导管腺癌:对未来的诊断和治疗
机译:转移性胰腺导管腺癌的外科治疗:目前文学的综述
机译:使用谐波运动成像(HMI)在体内和在手术后的人类标本中检测胰管腺癌的方法和治疗监测
机译:ZNF300可能影响胰腺导管腺癌的转移特性。
机译:在NAPOLI-1研究方案后采用纳尔伊立替康+ 5-FU在第二行中序贯治疗胰腺转移性肝癌并伴有肝转移
机译:转移性胰腺导管腺癌:对未来的诊断和治疗